Rules allow drug developers to list on the bourse before they sell any products to patients
Related Posts
Beijing bristles at Hagel warning
Founder Group’s legal spat imperils Credit Suisse move in China
Manulife Asset Management Appoints Peter Warnes In Senior Role
Hong Kong seizes biggest illegal ivory haul in three decades
Songdu shares: the actual controller was investigated for suspected insider trading and has nothing to do with the company
South China Sea spat sours summit- A unanimous response on North Korea is the only viable option
- Steady business operation as scheduled to redeem bonds, the established retail giant Gome, stable and far-reaching-
- Chinese Military Secrets Leaked on Video Game Forum
European luxury groups defy slowdown fears